CANDEL THERAPEUTICS, INC. (CADL) Operating income 2020–2025
CANDEL THERAPEUTICS, INC. (CADL) annual operating income history from SEC filings — each fiscal year as reported.
-$48.3MFY2025 · since FY2020: -$13.8M → -$48.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$48.3M | -44.6% |
| FY2024 | -$33.4M | +13.1% |
| FY2023 | -$38.4M | -10.6% |
| FY2022 | -$34.7M | -35.0% |
| FY2021 | -$25.7M | -86.3% |
| FY2020 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice